Cited by 1,043Neurological diseases and metabolismParkinson's Disease Mechanisms and TreatmentsTrace Elements in Health

The DOI matches its Crossref record.

ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA

DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E, LEES, A. J., JENNER, P., MARSDEN, C. D.·1991·Brain

DOI 10.1093/brain/114.4.1953

Open this paper in CoChat — free account

Abstract

Levels of iron, copper, zinc and manganese were measured by inductively coupled plasma spectroscopy in frozen postmortem brain tissue from patients with Parkinson's disease (PD), progressive supranuclear palsy (PSP), multiple system atrophy with strionigral degeneration (MSA), and Huntington's disease (HD) compared with control subjects. Total iron levels were found to be elevated in the areas of basal ganglia showing pathological change in these disorders. In particular, total iron content was increased in substantia nigra in PD, PSP and MSA, but not in HD. Total iron levels in the striatum (putamen and/or caudate nucleus) were increased in PSP, MSA and HD but not in PD. Total iron levels were decreased in the globus pallidus in PD. There were no consistent alterations of manganese levels in basal ganglia structures in any of the diseases studied. Copper levels were decreased in the substantia nigra in PD, and in the cerebellum in PSP, and were elevated in the putamen and possibly substantia nigra in HD. Zinc levels were only increased in PD, in substantia nigra and in caudate nucleus and lateral putamen. Levels of the iron binding protein ferritin were measured in the same patient groups using a radio-immunoassay technique. Increased iron levels in basal ganglia were generally associated with normal or elevated levels of ferritin immunoreactivity, for example, the substantia nigra in PSP and possibly MSA, and in putamen in MSA. The exception was PD where there was a generalized reduction in brain ferritin immunoreactivity, even in the substantia nigra. An increase in total iron content appears to be a response to neurodegeneration in affected basal ganglia regions in a number of movement disorders. However, only in PD was there an increased total iron level, decreased ferritin content, decreased copper content, and an increased zinc concentration in substantia nigra. These findings suggest an alteration of iron handling in the substantia nigra in PD. Depending on the form in which the excess iron load exists in nigra in PD, it may contribute to the neurodegenerative process.

Integrity signals

Registry

Crossref · 10.1093/brain/114.4.1953

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 201–300 of 1,000

Coordination Features and Affinity of the Cu2+ Site in the α-Synuclein Protein of Parkinson’s Disease
Dudzik, C. G., Walter, É., & Millhauser, G. L. (2011) · Biochemistry · doi:10.1021/bi101912q · Cited by 120
Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases
Leveugle, B., Faucheux, B. A., Bouras, C., Nillesse, N., Spik, G., Hirsch, É. C., Agid, Y., & Hof, P. R. (1996) · Acta Neuropathologica · doi:10.1007/s004010050468 · Cited by 120
Self-citation
Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson’s disease
Foley, P., & Riederer, P. F. (2000) · Journal of Neurology · doi:10.1007/pl00007766 · Cited by 119
Experimental Destruction of Substantia Nigra Initiated by Parkinson Disease Immunoglobulins
Chen, S., Le, W.-D., Xie, W., Alexianu, M. E., Engelhardt, J. I., Siklós, L., & Appel, S. H. (1998) · Archives of Neurology · doi:10.1001/archneur.55.8.1075 · Cited by 118
Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson’s disease
McNaught, K. S. P., Carrupt, P., Altomare, C., et al. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00142-7 · Cited by 118
Self-citation
Modifications of the iron–neuromelanin system in Parkinson's disease
Fasano, M., Bergamasco, B., & Lopiano, L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03638.x · Cited by 117
Free radicals in Parkinson's disease
Koutsilieri, E., Scheller, C., Grünblatt, E., Keinosuke, N. A. R. A., Li, J., & Riederer, P. F. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1201-7 · Cited by 117
Iron and reactive oxygen species activity in parkinsonian substantia nigra
del Nogal, A. W., Gałązka-Friedman, J., Bauminger, E. R., Wszołek, Z. K., Schweitzer, K. J., Dickson, D. W., Jaklewicz, A., Elbaum, D., & Friedman, A. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.02.007 · Cited by 117
Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease
Faucheux, B. A., Martin, M., Beaumont, C., Hunot, S., Hauw, J., Agid, Y., & Hirsch, E. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01118.x · Cited by 116
“In contrast, unchanged or low levels of ferritin subunits have been reported in the SNpc of parkinsonian patients in spite of iron accumulation (Dexter et al. 1991; Mann et al. 1994).”
BackgroundResultSelf-citation
The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: A hypothesis
Enochs, W. S., Sarna, T., Zecca, L., Riley, P. A., & Swartz, H. M. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260963 · Cited by 116
Recognition memory impairment and brain oxidative stress induced by postnatal iron administration
de Lima, M. N. M., Polydoro, M., Laranja, D. C., Bonatto, F., Bromberg, E., Moreira, J. C. F., Dal‐Pizzol, F., & Schröder, N. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04083.x · Cited by 119
Iron: A New Target for Pharmacological Intervention in Neurodegenerative Diseases
Whitnall, M., & Richardson, D. R. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.08.008 · Cited by 113
Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson’s disease
Thomas, G. E. C., Zarkali, A., Ryten, M., Shmueli, K., Gil-Martínez, A. L., Leyland, L., McColgan, P., Acosta‐Cabronero, J., Lees, A. J., & Weil, R. S. (2021) · Brain · doi:10.1093/brain/awab084 · Cited by 112
Self-citation
Role of brain iron accumulation in cognitive dysfunction: evidence from animal models and human studies
Schröder, N., Figueiredo, L. S., & de Lima, M. N. M. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121996 · Cited by 113
An iron–dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta
Hare, D. J., Lei, P., Ayton, S., Roberts, B. R., Grimm, R., George, J. L., Bishop, D., Beavis, A. D., Donovan, S. J., McColl, G., et al. (2014) · Chemical Science · doi:10.1039/c3sc53461h · Cited by 114
Iron in Multiple Sclerosis and Its Noninvasive Imaging with Quantitative Susceptibility Mapping
Stüber, C., Pitt, D., & Wang, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010100 · Cited by 117
Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease
Gerlach, M., Double, K. L., Ben‐Shachar, D., Zecca, L., Youdim, M. B. H., & Riederer, P. F. (2003) · Neurotoxicity Research · doi:10.1007/bf03033371 · Cited by 112
Assessment of trace elements in human brain using inductively coupled plasma mass spectrometry
Krebs, N., Langkammer, C., Goessler, W., Ropele, S., Fazekas, F., Yen, K., & Scheurer, E. (2013) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2013.09.006 · Cited by 112
DJ-1 knock-down in astrocytes impairs astrocyte-mediated neuroprotection against rotenone
Mullett, S. J., & Hinkle, D. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.09.013 · Cited by 113
Brain iron accumulation in aging and neurodegenerative disorders
Hagemeier, J., Geurts, J. J. G., & Zivadinov, R. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.128 · Cited by 114
Inflaming the Brain with Iron
Urrutia, P. J., Bórquez, D. A., & Núñez, M. T. (2021) · Antioxidants · doi:10.3390/antiox10010061 · Cited by 131
Using High-Resolution MR Imaging at 7T to Evaluate the Anatomy of the Midbrain Dopaminergic System
Eapen, M., Zald, D. H., Gatenby, J. C., Ding, Z., & Gore, J. C. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2355 · Cited by 109
The clinical utility of QSM: disease diagnosis, medical management, and surgical planning
Eskreis‐Winkler, S., Zhang, Y., Zhang, J., Liu, Z., Dimov, A., Gupta, A. K., & Wang, Y. (2016) · NMR in Biomedicine · doi:10.1002/nbm.3668 · Cited by 109
Neonatal Iron Exposure Induces Neurobehavioural Dysfunctions in Adult Mice
Fredriksson, A., Schröder, N., Eriksson, P., Izquierdo, I., & Archer, T. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8711 · Cited by 108
Assessing Plasma Levels of Selenium, Copper, Iron and Zinc in Patients of Parkinson’s Disease
Hai-wen, Z., Lin, J., Wang, X., Cheng, X., Wang, J., Hu, B., Zhang, Y., Zhang, X., & Zhu, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083060 · Cited by 109
Common and Trace Metals in Alzheimer’s and Parkinson’s Diseases
Doroszkiewicz, J., Farhan, J. A., Mroczko, J., Winkel, I., Perkowski, M., & Mroczko, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115721 · Cited by 108
Age at onset as a factor in determining the phenotype of primary torsion dystonia
O’Riordan, S., Raymond, D., Lynch, T., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000142035.26034.c2 · Cited by 105
Metalloproteomics and metal toxicology of α-synuclein
Santner, A. A., & Uversky, V. N. (2010) · Metallomics · doi:10.1039/b926659c · Cited by 104
Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin‐bound and free iron into the rat brain
Deane, R., Zheng, W., & Zloković, B. V. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02221.x · Cited by 104
Manganese: A transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of Parkinsonism
Sziráki, I., Mohanakumar, K. P., Rauhala, P. V., Kim, H. G., YEH, K., & Chiueh, C. C. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00660-x · Cited by 106
To Eat or to Die: Deciphering Selective Forms of Autophagy
Abdrakhmanov, A., Gogvadze, V. G., & Zhivotovsky, B. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.11.006 · Cited by 110
Iron and Neurodegeneration: Is Ferritinophagy the Link?
Biasiotto, G., Lorenzo, D. D., Archetti, S., & Zanella, I. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9473-y · Cited by 105
Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: What does it mean?
Kim, Y. K., Kim, J., Kim, J. ‐., et al. (2002) · Movement Disorders · doi:10.1002/mds.10089 · Cited by 104
Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice
Zou, L., Xu, J., Jankovic, J. J., He, Y., Appel, S. H., & Le, W. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00853-3 · Cited by 103
Forcing Nonamyloidogenic β-Synuclein To Fibrillate
Yamin, G., Munishkina, L. A., Karymov, M. A., Lyubchenko, Y. L., Uversky, V. N., & Fink, A. L. (2005) · Biochemistry · doi:10.1021/bi048778a · Cited by 103
Low levels of arsenite activates nuclear factor‐κB and activator protein‐1 in immortalized mesencephalic cells
Felix, K., Manna, S. K., WISE, K. C., Barr, J. L., & Ramesh, G. T. (2005) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20062 · Cited by 103
Influence of neuromelanin on oxidative pathways within the human substantia nigra
Double, K. L., Ben-Shachar, D., Youdim, M. B. H., Zecca, L., Riederer, P., & Gerlach, M. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00218-0 · Cited by 102
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
Finkelstein, D. I., Billings, J. L., Adlard, P. A., Ayton, S., Sedjahtera, A., Masters, C. L., Wilkins, S., Shackleford, D. M., Charman, S. A., Bal, W., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0456-2 · Cited by 104
The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System
Joppe, K., Roser, A., Maass, F., & Lingor, P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00015 · Cited by 103
Redox active metals in neurodegenerative diseases
Acevedo, K. M., Masaldan, S., Opazo, C., & Bush, A. I. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01731-9 · Cited by 102
Iron in parkinsonian and control substantia nigra—A mössbauer spectroscopy study
Gałązka-Friedman, J., Bauminger, E. R., Friedman, A., Barcikowska, M., Hechel, D., & Nowik, I. (1996) · Movement Disorders · doi:10.1002/mds.870110104 · Cited by 102
Manganese Transport in the Neural Circuit of Rat CNS
Takeda, A., Kodama, Y., Ishiwatari, S., et al. (1998) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00330-4 · Cited by 101
Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson’s disease
Liu, B. (2006) · The AAPS Journal · doi:10.1208/aapsj080369 · Cited by 100
The role of oxidative stress in Huntington’s disease: Are antioxidants good therapeutic candidates?
Gil-Mohapel, J., Brocardo, P., & Christie, B. (2014) · Current Drug Targets · doi:10.2174/1389450115666140115113734 · Cited by 101
Multimodal MRI assessment of nigro‐striatal pathway in multiple system atrophy and Parkinson disease
Barbagallo, G., Peña, M. S., Nemmi, F., Traon, A. P., Meissner, W. G., Rascol, O., & Péran, P. (2015) · Movement Disorders · doi:10.1002/mds.26471 · Cited by 100
Brain Accumulation and Toxicity of Mn(II) and Mn(III) Exposures
Reaney, S. H., Bench, G., & Smith, D. R. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl028 · Cited by 99
Multiple System Atrophy
Wenning, G. K., & Braune, S. (2001) · CNS Drugs · doi:10.2165/00023210-200115110-00003 · Cited by 102
MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy
Péran, P., Barbagallo, G., Nemmi, F., Sierra, M., Galitzky, M., Traon, A. P., Payoux, P., Meissner, W. G., & Rascol, O. (2018) · Movement Disorders · doi:10.1002/mds.27307 · Cited by 98
Impairment of Interrelated Iron- and Copper Homeostatic Mechanisms in Brain Contributes to the Pathogenesis of Neurodegenerative Disorders
Skjørringe, T., Møller, L. B., & Moos, T. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00169 · Cited by 104
Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease
Scheider, W. L., Hershey, L. A., Vena, J. E., Holmlund, T., Marshall, J. R., & Freudenheim, J. L. (1997) · Movement Disorders · doi:10.1002/mds.870120209 · Cited by 98
Impaired iron homeostasis in Parkinson’s disease
Double, K. L., Gerlach, M., Youdim, M. B. H., & Riederer, P. F. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_3 · Cited by 101
Chelation therapy for neurodegenerative diseases
Bolognin, S., Drago, D., Luigi Messori, A., & Zatta, P. F. (2009) · Medicinal Research Reviews · doi:10.1002/med.20148 · Cited by 98
Differentiation between Parkinson disease and other forms of Parkinsonism using support vector machine analysis of susceptibility-weighted imaging (SWI): initial results
Haller, S., Badoud, S., Nguyen, D. D., Barnaure, I., Montandon, M.-L., Lövblad, K., & Burkhard, P. (2012) · European Radiology · doi:10.1007/s00330-012-2579-y · Cited by 97
Inhibition of Prolyl Hydroxylase Protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Neurotoxicity
Lee, D. W., Rajagopalan, S., Siddiq, A., Gwiazda, R. H., Yang, L., Beal, M. F., Ratan, R. R., & Andersen, J. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000638 · Cited by 97
Deferoxamine Attenuates Iron-Induced Oxidative Stress and Prevents Mitochondrial Aggregation and α-Synuclein Translocation in SK-N-SH Cells in Culture
Sangchot, P., Sharma, S., Chetsawang, B., Porter, J. E., Govitrapong, P., & Ebadi, M. (2002) · Developmental Neuroscience · doi:10.1159/000065700 · Cited by 97
Drosophila melanogaster Models of Metal-Related Human Diseases and Metal Toxicity
Calap-Quintana, P., González-Fernández, J., Sebastiá-Ortega, N., Llorens, J. V., & Moltó, M. D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071456 · Cited by 100
Brain Iron Accumulation in Atypical Parkinsonian Syndromes: in vivo MRI Evidences for Distinctive Patterns
Lee, J., & Lee, M. S. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00074 · Cited by 95
Regional distributions of manganese, iron, copper, and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats
Tarohda, T., Ishida, Y., Kawai, K., Yamamoto, M., & Amano, R. (2005) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-005-3423-x · Cited by 95
Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping
An, H., Zeng, X., Niu, T., Li, G., Yang, J., Zheng, L., Zhou, W., Liu, H., Zhang, M., Huang, D., et al. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.01.008 · Cited by 98
Parkinson Disease Protein DJ-1 Binds Metals and Protects against Metal-induced Cytotoxicity
Björkblom, B., Adilbayeva, A., Maple‐Grødem, J., Piston, D., Ökvist, M., Xu, X. M., Brede, C., Larsen, J. P., & Møller, S. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.482091 · Cited by 99
Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy.
Pérez, M., Valpuesta, J., de Garcini, E. M., Quintana, C., Arrasate, M., Carrascosa, J. L., Rábano, A., de Yébenes, J. G., & Ávila, J. (1998) · Europe PMC (PubMed Central) · Cited by 94
Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease
Boll, M.-C., Sotelo, J., Otero, E., Alcaraz-Zubeldia, M., & Rios, C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00221-9 · Cited by 92
Dietary Iron Intake and Risk of Parkinson's Disease
Logroscino, G., Gao, X., Chen, H., Wing, A., & Ascherio, A. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn273 · Cited by 93
Role and Mechanism of Microglial Activation in Iron-Induced Selective and Progressive Dopaminergic Neurodegeneration
Zhang, W., Yan, Z., Gao, J., Sun, L., Huang, X., Liu, Z., Yu, S., Cao, C.-J., Zuo, L.-J., Chen, Z., et al. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8586-4 · Cited by 91
Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson’s disease
Méndez‐Álvarez, E., Soto‐Otero, R., Ameijeiras, A. H., et al. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00077-1 · Cited by 92
Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection
da Silva, V. K., de Freitas, B. S., da Silva Dornelles, A., Nery, L. R., Falavigna, L., Ferreira, R. D. P., Bogo, M. R., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8514-7 · Cited by 91
“Iron accumulation in neurons, astrocytes, and microglia has been reported in the basal ganglia as well as in the cortex and hippocampus, regions affected in neurodegenerative diseases such as Parkinson's disease (PD), Alzheimer's disease (AD), and multiple sclerosis (MS) [2–9].”
Oxidatively generated DNA damage after Cu(II) catalysis of dopamine and related catecholamine neurotransmitters and neurotoxins: Role of reactive oxygen species
Spencer, W. A., Jeyabalan, J., Kichambre, S., & Gupta, R. C. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.10.693 · Cited by 93
l-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats
Saravanan, K. S., Madathil, S. K., Karuppagounder, S. S., & Mohanakumar, K. P. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.016 · Cited by 92
The neurotoxicity of iron, copper and cobalt in Parkinson’s disease through ROS-mediated mechanisms
Lan, A. P., Chen, J., Chai, Z., & Hu, Y. (2016) · BioMetals · doi:10.1007/s10534-016-9942-4 · Cited by 92
Magnetic Resonance Imaging Evidence of Decreased Putamenal Iron Content in Idiopathic Parkinson's Disease
Ryvlin, P., Broussolle, E., Piollet, H., Viallet, F., Khalfallah, Y., & Chazot, G. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540300057013 · Cited by 90
Magnetic resonance imaging of brain iron in health and disease
Vymazal, J., Brooks, R. A., Patronas, N. J., Hájek, M., Bulte, J. W. M., & Chiro, G. D. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00204-f · Cited by 88
Brain iron homeostasis
Morris, C. M., Candy, J. M., Keith, A. B., Oakley, A. E., Taylor, G. A., Edwardson, J. A., Bloxham, C. A., Pullen, R. G. L., & Gocht, A. (1992) · Journal of Inorganic Biochemistry · doi:10.1016/0162-0134(92)84071-t · Cited by 90
Functional relevance of ceruloplasmin mutations in Parkinson's Disease
Hochstrasser, H., Tomiuk, J., Walter, U., Behnke, S., Spiegel, J., Krüger, R., Becker, G., Riess, O., & Berg, D. (2005) · The FASEB Journal · doi:10.1096/fj.04-3486fje · Cited by 87
Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease
Riederer, P. F., Dirr, A., Goetz, M. E., Sofic, E., Jellinger, K. A., & Youdimt, M. B. H. (1992) · Annals of Neurology · doi:10.1002/ana.410320717 · Cited by 88
Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period
Fredriksson, A., Schröder, N., Eriksson, P., Izquierdo, I., & Archer, T. (2000) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00160-1 · Cited by 86
Correlation of R2 with total iron concentration in the brains of rhesus monkeys
Hardy, P., Gash, D., Yokel, R., Andersen, A., Ai, Y., & Zhang, Z.-M. (2005) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20244 · Cited by 93
Lateral Asymmetry and Spatial Difference of Iron Deposition in the Substantia Nigra of Patients with Parkinson Disease Measured with Quantitative Susceptibility Mapping
Azuma, M., Hirai, T., Yamada, K., Yamashita, S., Ando, Y., Tateishi, M., Iryo, Y., Yoneda, T., Kitajima, M., Wang, Y., et al. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4645 · Cited by 88
Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism
Dekker, M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00713-4 · Cited by 87
Oxidative stress and Alzheimer's disease
Choi, B. H. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00065-m · Cited by 86
Oxidation-induced ferritin turnover in microglial cells: role of proteasome
Mehlhase, J., Sandig, G., Pantopoulos, K., & Grune, T. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.025 · Cited by 84
The murine pantothenate kinase ( Pank1 ) gene encodes two differentially regulated pantothenate kinase isozymes
Rock, C. O., Karim, M. A., Zhang, Y.-M., et al. (2002) · Gene · doi:10.1016/s0378-1119(02)00564-4 · Cited by 85
Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation
McNaught, K. S. P., & Jenner, P. G. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00415-9 · Cited by 86
Self-citation
Microstructural and volumetric abnormalities of the putamen in juvenile myoclonic epilepsy
Keller, S. S., Ahrens, T., Mohammadi, S., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03117.x · Cited by 84
Effects of alpha‐synuclein post‐translational modifications on metal binding
González, N., Arcos‐López, T., König, A., Quintanar, L., Menacho-Márquez, M., Outeiro, T. F., & Fernández, C. O. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14721 · Cited by 83
A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3
Guimarães, R., D’Abreu, A., Yasuda, C. L., França, M. C., Silva, B. H. B., Cappabianco, F. A. M., Bergo, F. P. G., Lopes-Cendes, Í. T., & Cendes, F. (2013) · Movement Disorders · doi:10.1002/mds.25451 · Cited by 84
Elevation of antioxidant potency in the brain of mice by low-dose γ-ray irradiation and its effect on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced brain damage
Kojima, S., Matsuki, O., Nomura, T., Yamaoka, K., Takahashi, M., & Niki, E. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00200-7 · Cited by 83
The involvement of dityrosine crosslinking in α-synuclein assembly and deposition in Lewy Bodies in Parkinson’s disease
Al‐Hilaly, Y. K., Biasetti, L., Blakeman, B. J. F., Pollack, S. J., Zibaee, S., Abdul‐Sada, A. K., Thorpe, J. R., Xue, W., & Serpell, L. C. (2016) · Scientific Reports · doi:10.1038/srep39171 · Cited by 85
The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
Minakaki, G., Krainc, D., & Burbulla, L. F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.580634 · Cited by 87
Generation of Reactive Oxygen Species by Mitochondrial Complex I: Implications in Neurodegeneration
Fato, R., Bergamini, C., Leoni, S., Strocchi, P., & Lenaz, G. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9747-0 · Cited by 81
Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates
Verina, T., Kiihl, S. F., Schneider, J. S., & Guilarte, T. R. (2010) · NeuroToxicology · doi:10.1016/j.neuro.2010.11.003 · Cited by 82
Impairment of emotional behavior and spatial learning in adult Wistar rats by ferrous sulfate
Maâroufi, K., Ammari, M., Jeljeli, M., Roy, V., Sakly, M., & Abdelmelek, H. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.10.019 · Cited by 83
In vitro aggregation assays for the characterization of α-synuclein prion-like properties
Narkiewicz, J., Giachin, G., & Legname, G. (2014) · Prion · doi:10.4161/pri.28125 · Cited by 86
The Role of Osteopontin in Neurodegenerative Diseases
Carecchio, M., & Comi, C. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-102151 · Cited by 79
Metal changes in CSF and peripheral compartments of parkinsonian patients
Bocca, B., Alimonti, A., Senofonte, O., Pino, A., Violante, N., Petrucci, F., Sancesario, G., & Forte, G. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.007 · Cited by 82
Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited
Langley, J. A., Huddleston, D. E., Merritt, M. D., Chen, X., McMurray, R., Silver, M., Factor, S. A., & Hu, X. P. (2016) · Human Brain Mapping · doi:10.1002/hbm.23192 · Cited by 78
Oxidative stress and Parkinson's disease
Jenner, P. G. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83024-7 · Cited by 79
Self-citation
Activation of Wnt/β-catenin Pathway by Exogenous Wnt1 Protects SH-SY5Y Cells Against 6-Hydroxydopamine Toxicity
Wei, L., Sun, C., Lei, M., Li, G., Yi, L., Luo, F., Li, Y., Ding, L., Liu, Z., Li, S., et al. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9900-8 · Cited by 79
New Progress on the Role of Glia in Iron Metabolism and Iron-Induced Degeneration of Dopamine Neurons in Parkinson’s Disease
Xu, H., Wang, Y., Song, N., Wang, J., Jiang, H. F., & Xie, J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00455 · Cited by 82
Age-related neurodegeneration and oxidative stress: putative nutritional intervention.
Joseph, J., Denisova, N., Fisher, D., Shukitt-Hale, B., Bickford, P., Prior, R., & Cao, G. (1998) · Neurologic clinics · doi:10.1016/s0733-8619(05)70092-x · Cited by 85
Etiology of Parkinson's Disease
Huang, Z., de la Fuente‐Fernández, R., & Stoessl, A. J. (2003) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710000319x · Cited by 81

Authors: DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D.
Affiliations: King's College London (GB)
Inserm (FR)
Parkinson's UK (GB)
Corresponding author: JENNER, P.
ORCID: DEXTER, D. T.
DANIEL, S. E
LEES, A. J.
JENNER, P.
Venue: Brain
Publisher: Oxford University Press (OUP)
Published: 1991
Volume: 114
Issue: 4
Pages: 1953-1975
ISSN: 0006-8950 (ISSN-L)
1460-2156
DOI: 10.1093/brain/114.4.1953
OpenAlex: W2123913108
Cited by: 1,043
References: 0
Citations by year: 2026: 18 · 2025: 29 · 2024: 47 · 2023: 28 · 2022: 37 · 2021: 43 · 2020: 36 · 2019: 38 · 2018: 30 · 2017: 45 · 2016: 56 · 2015: 45 · 2014: 41 · 2013: 44 · 2012: 32
FWCI: 12.57
Type: journal article
Language: en
Open access: closed
Locations: Brain (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Funders: Royal Society
Topics: Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
Keywords: Parkinson's disease, progressive supranuclear palsy, multiple system atrophy, Huntington's disease, basal ganglia, iron, ferritin, copper, zinc, manganese, substantia nigra, striatum, globus pallidus, neurodegeneration, trace metals, iron overload
MeSH terms: Aging, Atrophy, Basal Ganglia Diseases, Brain, Brain Diseases, Ferritins, Humans, Huntington Disease, Iron, Metals, Parkinson Disease, Radioimmunoassay, Reference Values, Supranuclear Palsy, Progressive, Trace Elements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks